-

AVI Publishes Open Letter to Directors of Third Point Investors Limited to Call General Meeting

LONDON--(BUSINESS WIRE)--Asset Value Investors (AVI), manager of the £1.2bn AVI Global Trust (AGT) and three other shareholders in Third Point Investors Limited (TPIL) collectively owning over 17 per cent. of its ordinary shares and over 10 per cent. of the voting rights have today requisitioned the TPIL Board to convene an extraordinary general meeting of TPIL to consider and if thought fit pass a resolution to change its investment policy. The resolution is aimed at fixing TPIL’s persistent and entrenched trading discount to NAV.

Tom Treanor, Executive Director, Asset Value Investors, comments:The proposed new investment policy would see TPIL use its existing contractual authority to redeem shares in the Master Fund and use the proceeds to fund redemptions of Ordinary Shares at NAV less costs on a quarterly basis. We recommend that simultaneously, Shareholders (whether existing Shareholders or not) should be allowed to submit subscription requests at the same price at which redemptions are made.

“The proposed new investment policy would place no obligation on any Shareholder to redeem any of its investment in TPIL – simply an ability to do so, at a price close to NAV. Nor should it have any material impact on NAV returns for those Shareholders who wish to remain invested. Indeed, these are liquidity terms that Third Point has had no problem honouring for other investors since the firm’s inception.”

A letter providing some background to the action AVI is taking can be found by clicking on the following link:

https://www.aviglobal.co.uk/campaign/avi-requisitions-third-point-investors-to-call-an-egm/

Notes to editors

About Asset Value Investors (AVI)

AVI was established in 1985 to take over the management of one of the oldest listed investment companies in London, now called AVI Global Trust. Our distinctive approach of investing in family-controlled companies, closed-end funds (CEFs) and asset backed situations is still a unique combination 35 years later. Constructive engagement with investee Boards to improve governance and reduce discounts is central to our investments in CEFs.

Constructive Activism

Asset Value Investors (AVI) has a long history of engagement with investee companies in Europe and Asia. The team often interacts with the Board and management to unlock shareholder value and promote high standards of corporate governance.

Contacts

Tom Treanor
Tom.treanor@assetvalueinvestors.com
+44 20 7659 4800

Asset Value Investors


Release Versions

Contacts

Tom Treanor
Tom.treanor@assetvalueinvestors.com
+44 20 7659 4800

Social Media Profiles
More News From Asset Value Investors

AVI Calls for Changes at Gerresheimer

LONDON--(BUSINESS WIRE)--Asset Value Investors (“AVI”) has sent an open letter to the Supervisory Board of Gerresheimer AG (“Gerresheimer”) calling for it to make changes to its financial leadership. You can find the published letter here. AVI invested in Gerresheimer in 2024 and manages a 3.5% stake on behalf of institutional clients. Gerresheimer holds a valuable position in the Containment Solutions & Delivery Systems industry, with high barriers to entry and attractive long-term growth...

AVI Urges Wacom To Make Governance Changes

LONDON--(BUSINESS WIRE)--Asset Value Investors Limited (“AVI”) launches a campaign calling for Wacom Corporation (“Wacom”) to be more conscious of the capital market, and announces that AVI has submitted shareholder proposals ahead of Wacom’s upcoming AGM in June. AVI has published a detailed presentation on a dedicated website. AVI invested in Wacom in August 2021 and has sought to engage in dialogue with the company as the largest shareholder, sending letters and presentations with the aim of...

Asset Value Investors Urges Rohto Pharmaceutical to Focus on Core Businesses and Engage With Shareholders More Constructively

LONDON--(BUSINESS WIRE)--Asset Value Investors Limited (‘AVI’) launches a campaign calling for Rohto Pharmaceutical (‘Rohto’) to focus on its core businesses rather than allocating resources to the unsuccessful regenerative medicine business, and to engage with shareholders more constructively to comply with the Tokyo Stock Exchange’s (‘TSE’) request for management that is conscious of the cost of capital and stock price. A detailed presentation can be found here. Since AVI started investing in...
Back to Newsroom